Phthalate metabolite mixtures and dose-response associations with depressive symptoms in U.S. adults

Depression is a significant global health challenge. Emerging evidence links phthalate exposure to depressive symptoms, but population-based data are limited. This study aims to examine the impact of Mono-Phthalate Acid Esters (mPAEs) exposure on depressive symptoms in a general adult population and...

Full description

Saved in:
Bibliographic Details
Main Authors: Penghui Li, Huimin Zhang, Yike Han, Shuo Xie, Wanning Li, Liyun Kong, Yue Zhang
Format: Article
Language:English
Published: Elsevier 2025-09-01
Series:Ecotoxicology and Environmental Safety
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S014765132501231X
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849339384911888384
author Penghui Li
Huimin Zhang
Yike Han
Shuo Xie
Wanning Li
Liyun Kong
Yue Zhang
author_facet Penghui Li
Huimin Zhang
Yike Han
Shuo Xie
Wanning Li
Liyun Kong
Yue Zhang
author_sort Penghui Li
collection DOAJ
description Depression is a significant global health challenge. Emerging evidence links phthalate exposure to depressive symptoms, but population-based data are limited. This study aims to examine the impact of Mono-Phthalate Acid Esters (mPAEs) exposure on depressive symptoms in a general adult population and to characterize the dose-response relationship between urinary mPAEs and depressive symptoms. Data from the National Health and Nutrition Examination Survey (NHANES, 2005–2018) were used. A total of 9618 participants aged≥ 20 years were analyzed for 11 phthalate metabolites and depressive symptoms assessed via the Patient Health Questionnaire-9 (PHQ-9). Logistic regression, weighted quantile sum (WQS) regression, and quantile g-computation (QGC) models were employed to evaluate individual and mixture effects. The study identified significant associations between exposure to specific phthalate metabolites (MnBP, MiBP, MBzP, MEHHP, MECPP, BBP) and depressive symptoms in adults. Logistic regression showed that higher urinary concentrations of these metabolites were linked to increased depressive risk: compared to the lowest quartile (Q1), the highest quartile (Q4) had 50 %–88 % higher risk, with corresponding odds ratios (ORs) ranging from 1.50 (95 % CI: 1.19–1.89, P = 0.001) for MnBP to 1.88 (95 % CI: 1.53–2.31, P < 0.001) for MBzP. Trend tests confirmed significant linear relationships (all P-trend <0.05). Dose-response analysis using restricted cubic spline (RCS) revealed significant linear relationships for MnBP, MiBP, MBzP, and BBP (Poverall<0.05, Plinear <0.05), with no significant non-linear associations (Pnonlinear >0.05). Combined exposure analyses showed that MnBP, MBzP, and MEHHP contributed most to depressive symptoms risk: the WQS model indicated a significant positive overall effect of the mPAEs mixture (OR=1.23, 95 % CI: 1.08–1.41, P < 0.01), while the QGC model showed that each interquartile increase in the mixture was associated with an 18 % higher risk (OR=1.18, 95 % CI: 1.02–1.36, P < 0.05). Subgroup analyses indicated stronger associations among females and older adults (interaction P < 0.05 for gender and age). These findings underscore the adverse neuropsychiatric effects of PAEs exposure, emphasizing the need for safer alternatives to reduce population-level depressive symptoms risk. Further longitudinal studies are warranted to confirm causality and elucidate underlying mechanisms.
format Article
id doaj-art-75932f20e38b4f4fa2475c0b9e37ecc4
institution Kabale University
issn 0147-6513
language English
publishDate 2025-09-01
publisher Elsevier
record_format Article
series Ecotoxicology and Environmental Safety
spelling doaj-art-75932f20e38b4f4fa2475c0b9e37ecc42025-08-20T03:44:07ZengElsevierEcotoxicology and Environmental Safety0147-65132025-09-0130311888610.1016/j.ecoenv.2025.118886Phthalate metabolite mixtures and dose-response associations with depressive symptoms in U.S. adultsPenghui Li0Huimin Zhang1Yike Han2Shuo Xie3Wanning Li4Liyun Kong5Yue Zhang6School of Public Health, Xi’an Jiaotong University Health Science Center, Xi’an, Shaanxi 710061, China; Key Laboratory for Disease Prevention and Control and Health Promotion of Shaanxi Province, Xi’an, Shaanxi 710061, ChinaSchool of Public Health, Xi’an Jiaotong University Health Science Center, Xi’an, Shaanxi 710061, China; Key Laboratory for Disease Prevention and Control and Health Promotion of Shaanxi Province, Xi’an, Shaanxi 710061, ChinaSchool of Public Health, Xi’an Jiaotong University Health Science Center, Xi’an, Shaanxi 710061, China; Key Laboratory for Disease Prevention and Control and Health Promotion of Shaanxi Province, Xi’an, Shaanxi 710061, ChinaSchool of Public Health, Xi’an Jiaotong University Health Science Center, Xi’an, Shaanxi 710061, China; Key Laboratory for Disease Prevention and Control and Health Promotion of Shaanxi Province, Xi’an, Shaanxi 710061, ChinaSchool of Public Health, Xi’an Jiaotong University Health Science Center, Xi’an, Shaanxi 710061, China; Key Laboratory for Disease Prevention and Control and Health Promotion of Shaanxi Province, Xi’an, Shaanxi 710061, ChinaSchool of Public Health, Xi’an Jiaotong University Health Science Center, Xi’an, Shaanxi 710061, China; Key Laboratory for Disease Prevention and Control and Health Promotion of Shaanxi Province, Xi’an, Shaanxi 710061, China; Key Laboratory of Environment and Genes Related to Diseases (Xi’an Jiaotong University), Ministry of Education of China, Xi’an 710061, China; Corresponding author at: School of Public Health, Xi’an Jiaotong University Health Science Center, Xi’an, Shaanxi 710061, China.School of Public Health, Department of Epidemiology, Shanxi Medical University, Key Laboratory of Coal Environmental Pathogenicity and Prevention,Ministry Education, Taiyuan 030001, China; Corresponding author.Depression is a significant global health challenge. Emerging evidence links phthalate exposure to depressive symptoms, but population-based data are limited. This study aims to examine the impact of Mono-Phthalate Acid Esters (mPAEs) exposure on depressive symptoms in a general adult population and to characterize the dose-response relationship between urinary mPAEs and depressive symptoms. Data from the National Health and Nutrition Examination Survey (NHANES, 2005–2018) were used. A total of 9618 participants aged≥ 20 years were analyzed for 11 phthalate metabolites and depressive symptoms assessed via the Patient Health Questionnaire-9 (PHQ-9). Logistic regression, weighted quantile sum (WQS) regression, and quantile g-computation (QGC) models were employed to evaluate individual and mixture effects. The study identified significant associations between exposure to specific phthalate metabolites (MnBP, MiBP, MBzP, MEHHP, MECPP, BBP) and depressive symptoms in adults. Logistic regression showed that higher urinary concentrations of these metabolites were linked to increased depressive risk: compared to the lowest quartile (Q1), the highest quartile (Q4) had 50 %–88 % higher risk, with corresponding odds ratios (ORs) ranging from 1.50 (95 % CI: 1.19–1.89, P = 0.001) for MnBP to 1.88 (95 % CI: 1.53–2.31, P < 0.001) for MBzP. Trend tests confirmed significant linear relationships (all P-trend <0.05). Dose-response analysis using restricted cubic spline (RCS) revealed significant linear relationships for MnBP, MiBP, MBzP, and BBP (Poverall<0.05, Plinear <0.05), with no significant non-linear associations (Pnonlinear >0.05). Combined exposure analyses showed that MnBP, MBzP, and MEHHP contributed most to depressive symptoms risk: the WQS model indicated a significant positive overall effect of the mPAEs mixture (OR=1.23, 95 % CI: 1.08–1.41, P < 0.01), while the QGC model showed that each interquartile increase in the mixture was associated with an 18 % higher risk (OR=1.18, 95 % CI: 1.02–1.36, P < 0.05). Subgroup analyses indicated stronger associations among females and older adults (interaction P < 0.05 for gender and age). These findings underscore the adverse neuropsychiatric effects of PAEs exposure, emphasizing the need for safer alternatives to reduce population-level depressive symptoms risk. Further longitudinal studies are warranted to confirm causality and elucidate underlying mechanisms.http://www.sciencedirect.com/science/article/pii/S014765132501231XPhthalate metaboliteDepressive symptomsNHANESDose-response relationship
spellingShingle Penghui Li
Huimin Zhang
Yike Han
Shuo Xie
Wanning Li
Liyun Kong
Yue Zhang
Phthalate metabolite mixtures and dose-response associations with depressive symptoms in U.S. adults
Ecotoxicology and Environmental Safety
Phthalate metabolite
Depressive symptoms
NHANES
Dose-response relationship
title Phthalate metabolite mixtures and dose-response associations with depressive symptoms in U.S. adults
title_full Phthalate metabolite mixtures and dose-response associations with depressive symptoms in U.S. adults
title_fullStr Phthalate metabolite mixtures and dose-response associations with depressive symptoms in U.S. adults
title_full_unstemmed Phthalate metabolite mixtures and dose-response associations with depressive symptoms in U.S. adults
title_short Phthalate metabolite mixtures and dose-response associations with depressive symptoms in U.S. adults
title_sort phthalate metabolite mixtures and dose response associations with depressive symptoms in u s adults
topic Phthalate metabolite
Depressive symptoms
NHANES
Dose-response relationship
url http://www.sciencedirect.com/science/article/pii/S014765132501231X
work_keys_str_mv AT penghuili phthalatemetabolitemixturesanddoseresponseassociationswithdepressivesymptomsinusadults
AT huiminzhang phthalatemetabolitemixturesanddoseresponseassociationswithdepressivesymptomsinusadults
AT yikehan phthalatemetabolitemixturesanddoseresponseassociationswithdepressivesymptomsinusadults
AT shuoxie phthalatemetabolitemixturesanddoseresponseassociationswithdepressivesymptomsinusadults
AT wanningli phthalatemetabolitemixturesanddoseresponseassociationswithdepressivesymptomsinusadults
AT liyunkong phthalatemetabolitemixturesanddoseresponseassociationswithdepressivesymptomsinusadults
AT yuezhang phthalatemetabolitemixturesanddoseresponseassociationswithdepressivesymptomsinusadults